CTX-4430

DRUG5 trials

Sponsors

Celtaxsys, Inc.

Conditions

Acne VulgarisCystic FibrosisHealthyPulmonary Inflammation

Phase 1

Phase 1 Study Assessing the Safety and Tolerability of CTX-4430

CompletedNCT01748838

Celtaxsys, Inc.Pulmonary Inflammation

Start: 2012-12-31End: 2013-09-30Updated: 2013-09-10

Phase 1 Study Assessing the Safety and Tolerability of CTX-4430 in Cystic Fibrosis Patients

CompletedNCT01944735

Celtaxsys, Inc.Cystic Fibrosis

Start: 2013-09-30End: 2014-11-30Updated: 2015-03-06

Drug-Drug Interaction Study to Evaluate the Pharmacokinetics and Safety of CTX 4430 and Midazolam

CompletedNCT02233244

Celtaxsys, Inc.Healthy

Start: 2014-09-30End: 2014-10-31Updated: 2014-10-10

Phase 2

CTX-4430 for the Treatment of Moderate to Severe Facial Acne Vulgaris

CompletedNCT02385760

Celtaxsys, Inc.Acne Vulgaris

Start: 2015-04-30End: 2016-08-31Updated: 2016-08-02

EMPIRE CF: A Phase 2 Study to Evaluate the Efficacy, Safety, and Tolerability of CTX-4430 in Adult Cystic Fibrosis (CF) Patients

CompletedNCT02443688

Celtaxsys, Inc.Cystic Fibrosis

Start: 2015-10-30End: 2018-05-16Updated: 2019-09-04